Evidence map›Paper›PMID 42368856›Full record

ArticleFrontiers in cardiovascular medicine2026

Extracorporeal cardiac shock wave therapy modulates post-infarction neovascularization via CAC-mediated pro-angiogenic effects and modulation of the S100A4/CSF2/FOXO1 protein network.

Yang Li, Hao Li, Chen Liu, Xiaoying Zeng, Xin Tian, Wenwen Hu, Luqiao Wang, Baotong Hua, Ping Yang

Abstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yang Li *Cardiovascular Clinical Medicine Center, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Hao Li *Cardiovascular Clinical Medicine Center, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Chen LiuDepartment of Radiology, Second People's Hospital of Yunnan Province, Kunming, China.
Xiaoying ZengCardiovascular Clinical Medicine Center, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Xin TianSchool of Public Health, Kunming Medical University, Kunming, China.
Wenwen HuCardiovascular Clinical Medicine Center, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Luqiao WangCardiovascular Clinical Medicine Center, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Baotong HuaCardiovascular Clinical Medicine Center, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Ping YangCardiovascular Clinical Medicine Center, The First Affiliated Hospital of Kunming Medical University, Kunming, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ischemic heart disease (IHD) remains the leading cause of mortality worldwide, and the long-term benefits conferred by revascularization are limited. Cardiac shock wave therapy (CSWT) can promote neovascularization and attenuate myocardial injury, and has been applied in the treatment of IHD; its mechanism may involve Circulating Angiogenic cells (CACs) and their key proteins. This study aimed to explore the potential mechanism by which CSWT exerts effects on angiogenesis and attenuates structural damage following Acute Myocardial Infarction (AMI). Using

Indexed as

cardiac shock wave therapycirculating angiogenic cellsischemic heart diseasemyocardial repairneovascularization

Identifiers

PMID42368856
PMCPMC13303029

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.